MAGA hails Trump’s deal with Greenland – but is it any different from what the US already had? | One national security expert says the only thing that’s changed is that ‘our allies now think we’re led by a lunatic’

A newly discovered method for detecting early-stage Alzheimer’s disease through a simple blood test has shown promising results in identifying key biomarkers linked to the condition. Researchers highlight that this non-invasive approach could significantly reduce the need for costly and invasive diagnostic procedures like spinal taps or brain scans. The test focuses on identifying abnormal protein levels associated with Alzheimer’s progression, offering potential for earlier intervention and treatment. Early detection remains a critical challenge in combating the neurodegenerative disease, and this development could mark a major step forward in clinical diagnostics.